Matinas BioPharma Holdings (MTNB) Return on Capital Employed Growth (1y) (2015 - 2026)
Matinas BioPharma Holdings (MTNB) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 68,255.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 2,665.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 31,429.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2,503.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 16,829.00 |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | 4,723.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,723.00 |
| Dec 31, 2025 | 7,678.00 |
| Sep 30, 2025 | -4,439.00 |
| Jun 30, 2025 | -4,598.00 |
| Mar 31, 2025 | -8,636.00 |
| Dec 31, 2024 | -8,064.00 |
| Sep 30, 2024 | -2,672.00 |
| Jun 30, 2024 | -5,365.00 |
| Mar 31, 2024 | -6,165.00 |
| Dec 31, 2023 | -3,704.00 |
| Sep 30, 2023 | -2,417.00 |
| Jun 30, 2023 | -1,170.00 |
| Mar 31, 2023 | -899.00 |
| Dec 31, 2022 | -1,733.00 |
| Sep 30, 2022 | -1,921.00 |
| Jun 30, 2022 | -2,152.00 |
| Mar 31, 2022 | -1,278.00 |
| Dec 31, 2021 | -644.00 |
| Sep 30, 2021 | -642.00 |
| Jun 30, 2021 | -609.00 |